78 related articles for article (PubMed ID: 2049037)
1. Evasion of Yersinia enterocolitica serotype 03 from complement-mediated killing.
Pilz D; Wachter E; Heesemann J; Brade V
Behring Inst Mitt; 1991 Feb; (88):183-93. PubMed ID: 2049037
[TBL] [Abstract][Full Text] [Related]
2. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
3. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
4. Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products.
Schindler MK; Schütz MS; Mühlenkamp MC; Rooijakkers SH; Hallström T; Zipfel PF; Autenrieth IB
J Immunol; 2012 Nov; 189(10):4900-8. PubMed ID: 23071281
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.
Pilz D; Vocke T; Heesemann J; Brade V
Infect Immun; 1992 Jan; 60(1):189-95. PubMed ID: 1729182
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
7. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.
Patarakul K; Cole MF; Hughes CA
Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
Joiner KA; Warren KA; Tam M; Frank MM
J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
10. Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica.
Wachter E; Brade V
Infect Immun; 1989 Jul; 57(7):1984-9. PubMed ID: 2731980
[TBL] [Abstract][Full Text] [Related]
11. Activation of human complement by Yersinia enterocolitica: ultrastructural alterations and C3b-deposition.
Acker G; Brade V
Zentralbl Bakteriol A; 1980 Nov; 248(2):210-28. PubMed ID: 7223121
[TBL] [Abstract][Full Text] [Related]
12. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
Fuhrman SA; Joiner KA
J Immunol; 1989 Feb; 142(3):940-7. PubMed ID: 2643665
[TBL] [Abstract][Full Text] [Related]
13. Regulation of complement activation at the C3-level by serum resistant leptospires.
Meri T; Murgia R; Stefanel P; Meri S; Cinco M
Microb Pathog; 2005 Oct; 39(4):139-47. PubMed ID: 16169184
[TBL] [Abstract][Full Text] [Related]
14. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
Vogel U; Autenrieth IB; Berner R; Heesemann J
Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
[TBL] [Abstract][Full Text] [Related]
15. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
16. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
Ward CK; Inzana TJ
J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
[TBL] [Abstract][Full Text] [Related]
17. Plasmid-mediated surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis.
Kapperud G; Namork E; Skurnik M; Nesbakken T
Infect Immun; 1987 Sep; 55(9):2247-54. PubMed ID: 2887516
[TBL] [Abstract][Full Text] [Related]
18. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
Gutiérrez-Kobeh L; Cabrera N; Pérez-Montfort R
J Parasitol; 1997 Apr; 83(2):234-41. PubMed ID: 9105303
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
Joiner K; Brown E; Hammer C; Warren K; Frank M
J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
[TBL] [Abstract][Full Text] [Related]
20. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
